The impact of thiopurines on the risk of surgical recurrence in patients with crohn's disease after first intestinal surgery

American Journal of Gastroenterology

Volumn 105, Issue 5, 2010, Pages 1158-1164

  Papay, Pavol ^a   Reinisch, Walter ^a   Ho, Elien ^a   Gratzer, Cornelia ^a   Lissner, Donata ^a   Herkner, Harald ^a   Riss, Stefan ^a   Dejaco, Clemens ^a   Miehsler, Wolfgang ^a   Vogelsang, Harald ^a   Novacek, Gottfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; INTESTINE SURGERY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; REOPERATION; RISK FACTOR; SMOKING;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AZATHIOPRINE; COHORT STUDIES; COLECTOMY; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; POSTOPERATIVE CARE; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SMOKING; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951975185     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.673     Document Type: Article

References (28)

1. Whelan G, Farmer RG, Fazio VW et al. Recurrence aft er surgery in Crohn's disease. Gastroenterology 1985; 88: 1826-1833
2. Borley NR, Mortensen NJ, Chaudry MA et al. Recurrence aft er abdominal surgery for Crohn's disease. Dis Colon Rectum 2002; 45: 377-383
3. Cosnes J, Beaugerie L, Carbonnel F et al. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001; 120: 1093-1099
4. Caprilli R, Gassul MA, Escher JC et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006; 55 (Suppl I): i36-58.
5. Sutherland LR, Ramcharan S, Bryant H et al. Eff ect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990; 98: 1123-1128
6. Cottone M, Rosselli M, Orlando A et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994; 106: 643-648
7. Cosnes J, Carbonell F, Beaugerie L et al. Eff ects of cigarette smoking on the Long-term course of Crohn's disease. Gastroenterology 1996; 110: 424-431
8. Moskowitz D, McLeod RS, Greenberg GR et al. Operative and enviromental risk factors for recurrence of Crohn's disease. Int J Colorectal Dis 1999; 14: 224-226
9. Cottone M, Orlando A, Viscido A et al. Review article: prevention of postsurgical relapse in Crohn's disease. Aliment Pharmacol Ther 2003; 17 (Suppl 2): 38-42.
10. Avidan B, Sakhini E, Lahat A et al. Risk factors regarding the need for a second operation in patiens with Crohn's disease. Digestion 2005; 72: 248-253
11. Rutgeerts P, Feagan BG, Lichtenstein GR et al. Comparison of scheduled and episodic treatment strategies of infl iximab in Crohn's disease. Gastroenterology 2004; 126: 402-413
12. Lichtenstein GR, Yan S, Bala M et al. Infl iximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fi stulizing Crohn's disease. Gastroenterology 2005; 128: 862-869
13. Feagan BF, Panaccione R, Sandborn WJ et al. Eff ects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. Gastroenterology 2008; 135: 1493-1499
14. Sandborn WJ, Sutherland LR, Pearson D et al. Azathioprine or 6-mercaptopurine for inducing of remission in Crohn's disease. Cochrane Database Syst Rev 2000; (2): CD000545.
15. Pearson DC, May GR, Fick G et al. Azathioprine for maintenance of remission in Crohn's disease (Review). Cochrane Database Syst Rev 2000; (2): CD000067.
16. Pearson DC, May GR, Fick GH et al. Azathioprine and 6-mercaptopurine in Crohn's disease: a meta-analysis. Ann Intern Med 1995; 123: 132-142
17. Cosnes J, Nion-Larmurier I, Beaugerie L et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005; 54: 237-241
18. Vernier-Massouille G, Balde M, Salleron J et al. Natural history of pediatric Crohn's disease: a population based cohort study. Gastroenterology 2008; 135: 1106-1113
19. Picco MF, Zubiaurre I, Adluni M et al. Immunomodulators are associated with a lower risk of fi rst surgery among patients with non-penetrating non-stricturing Crohn's disease. Am J Gastroenterol 2009; 104: 2754-2759
20. Ardizzone S, Maconi G, Sampietro GM et al. Azathioprine and mesalamine for prevention of relapse aft er conservative surgery for Crohn's disease. Gastroenterology 2004; 127: 730-740
21. Sampietro GM, Corsi F, Maconi G et al. Prospective study of long-term results and prognostic factors aft er conservative surgery for small bowel Crohn's disease. Clin Gastroenterol Hepatol 2009; 7: 183-191
22. Alves A, Panis Y, Joly F et al. Could immunosuppressive drugs reduce recurrence rate aft er second resection for Crohn's disease? Infl amm Bowel Dis 2004; 10: 491-495
23. Peyrin-Biroulet L, Deltenre P, Ardizzone S et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol 2009; 104: 2089-96; doi:10.1038/ajg2009.301.
24. Stange EF, Travis SPL, Vermiere S et al. European evidence based consensus on the diagnosis and management of Crohn's disease: defi nitions and diagnosis. Gut 2006; 55 (Suppl I): i1-15.
25. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular, and serological classifi cation of infl ammatory bowel disease: report of a working party of the Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A): 5A-36A.
26. Oeff erlbauer-Ernst A, Miehsler W, Reinisch W, et al., and the Austrian IBDIS group. Interobserver agreement analysis of a national Infl ammatory Bowel Disease Information System (IBDIS). Gastroenterology 2003; 124: A507.
27. Present DH, Korelitz BI, Wisch N et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980; 302: 981-987 (Pubitemid 10125406)
28. Lemann M, Mary JY, Colombel JF et al. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology 2005; 128: 1812-1818